David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
NextDecade
NEXT
$1.94B
| $1.68M | ﹤0.01% |
218,975
+53,492
| +32% | +$304K |
|
2952
Celldex Therapeutics
CLDX
$3.19B
| $1.68M | ﹤0.01% |
52,860
-83,464
| -61% | -$2.28M |
|
2953
Mitek Systems
MITK
$862M
| $1.68M | ﹤0.01% |
124,112
-6,230
| -5% | -$77K |
|
2954
PUT
Ondas Inc
ONDS
$4.93B
| $1.67M | ﹤0.01% |
185,000
| – | – |
|
2955
Denison Mines
DNN
$3.3B
| $1.67M | ﹤0.01% |
471,600
-1,474,100
| -76% | -$5.54M |
|
2956
CALL
Atlassian
TEAM
$45.7B
| $1.67M | ﹤0.01% |
24,400
-50,500
| -67% | -$4.98M |
|
2957
Reliance Steel & Aluminium
RS
$19.9B
| $1.66M | ﹤0.01% |
5,478
-85,512
| -94% | -$27.2M |
|
2958
LivaNova
LIVN
$4.4B
| $1.66M | ﹤0.01% |
26,179
-86,779
| -77% | -$5.6M |
|
2959
CALL
AAR Corp
AIR
$5.48B
| $1.66M | ﹤0.01% |
+15,200
| New | +$1.64M |
|
2960
SmartFinancial
SMBK
$862M
| $1.66M | ﹤0.01% |
42,552
-7,178
| -14% | -$284K |
|
2961
John B. Sanfilippo & Son
JBSS
$855M
| $1.66M | ﹤0.01% |
20,957
+3,692
| +21% | +$284K |
|
2962
Bruker
BRKR
$9.03B
| $1.66M | ﹤0.01% |
45,924
-271,584
| -86% | -$11.4M |
|
2963
Rubrik
RBRK
$21.7B
| $1.65M | ﹤0.01% |
33,741
-871,799
| -96% | -$50M |
|
2964
QCR Holdings
QCRH
$1.66B
| $1.65M | ﹤0.01% |
19,296
+16,003
| +486% | +$1.39M |
|
2965
BW LPG
BWLP
$3.67B
| $1.65M | ﹤0.01% |
94,882
+5,447
| +6% | +$86.1K |
|
2966
PUT
D.R. Horton
DHI
$40.8B
| $1.65M | ﹤0.01% |
12,000
-13,100
| -52% | -$1.98M |
|
|
INFQ.WS
2967
Infleqtion Inc Warrants
INFQ.WS
| $1.64M | ﹤0.01% |
+371,250
| New | +$1.98M |
|
2968
Celsius Holdings
CELH
$8.5B
| $1.64M | ﹤0.01% |
+46,217
| New | +$2.19M |
|
2969
Farmers National Banc Corp
FMNB
$927M
| $1.64M | ﹤0.01% |
124,487
+91,617
| +279% | +$1.2M |
|
2970
Immersion
IMMR
$260M
| $1.64M | ﹤0.01% |
300,034
-104,809
| -26% | -$661K |
|
2971
Southern Missouri Bancorp
SMBC
$818M
| $1.64M | ﹤0.01% |
25,618
-7,451
| -23% | -$466K |
|
2972
Medifast
MED
$140M
| $1.64M | ﹤0.01% |
160,564
-58,554
| -27% | -$631K |
|
2973
CALL
Plug Power
PLUG
$3.17B
| $1.64M | ﹤0.01% |
723,600
-155,400
| -18% | -$337K |
|
2974
PUT
Teladoc Health
TDOC
$1.16B
| $1.64M | ﹤0.01% |
300,000
+200,100
| +200% | +$1.12M |
|
|
MTA
2975
Metalla Royalty & Streaming
MTA
$1.02B
| $1.63M | ﹤0.01% |
246,547
+62,084
| +34% | +$491K |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.